Physician profile
Stuart Weinberg
NPI 1750445615
$1,091.79
in general payments reported to CMS, 2019-2025
13 companies · $159 in 2025
The $159 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $92.93 · 2021: $203 · 2022: $156 · 2023: $101 · 2024: $261 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $622.64 | 2019-2025 | Bridion |
| Qol Medical, LLC | $92.84 | 2024 | Sucraid |
| Trevena, INC. | $73.22 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $56.04 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $49.12 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $45.28 | 2021-2022 | |
| Philips North America LLC | $31.10 | 2024 | (U09) Intellivue Stationary Monitoring |
| Mallinckrodt Hospital Products INC. | $26.93 | 2020 | |
| Heron Therapeutics, INC. | $22.96 | 2021 | |
| Acacia Pharma INC | $19.50 | 2021 | |
| Amarin Pharma, INC. | $18.07 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.63 | 2024 | Xifaxan |
| Draeger Medical Systems, INC | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Weinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.